 The FDA has lifted a partial clinical hold on a late-stage trial of Inovio Pharmaceuticals Incs NASDAQ: INO COVID-19 vaccine in the U.S. Inovio said it now has the authorization to proceed with the trial in the U.S. after 14 months. 